u-blox Holding Valuation
Is UBXN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UBXN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UBXN (CHF80.4) is trading below our estimate of fair value (CHF179.65)
Significantly Below Fair Value: UBXN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UBXN?
Other financial metrics that can be useful for relative valuation.
| What is UBXN's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF 592.00m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 7.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does UBXN's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.7x | ||
AMS ams-OSRAM | 0.3x | 6.4% | CHF 1.1b |
MBTN Meyer Burger Technology | 1.2x | 38.0% | CHF 158.4m |
WIHN WISeKey International Holding | 0.5x | 1.6% | CHF 12.4m |
A067310 HANA Micron | 0.9x | 26.3% | ₩880.2b |
UBXN u-blox Holding | 1x | -2.4% | CHF 592.0m |
Price-To-Sales vs Peers: UBXN is expensive based on its Price-To-Sales Ratio (1x) compared to the peer average (0.7x).
Price to Earnings Ratio vs Industry
How does UBXN's PE Ratio compare vs other companies in the European Semiconductor Industry?
Price-To-Sales vs Industry: UBXN is good value based on its Price-To-Sales Ratio (1x) compared to the European Semiconductor industry average (2.2x).
Price to Sales Ratio vs Fair Ratio
What is UBXN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1x |
| Fair PS Ratio | 0.5x |
Price-To-Sales vs Fair Ratio: UBXN is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 80.40 | CHF 85.33 +6.1% | 6.2% | CHF 90.00 | CHF 78.00 | n/a | 3 |
| Jul ’25 | CHF 92.70 | CHF 89.50 -3.5% | 9.5% | CHF 102.00 | CHF 78.00 | n/a | 4 |
| Jun ’25 | CHF 95.70 | CHF 89.50 -6.5% | 9.5% | CHF 102.00 | CHF 78.00 | n/a | 4 |
| May ’25 | CHF 85.10 | CHF 89.50 +5.2% | 9.5% | CHF 102.00 | CHF 78.00 | n/a | 4 |
| Apr ’25 | CHF 86.80 | CHF 88.75 +2.2% | 9.9% | CHF 102.00 | CHF 78.00 | n/a | 4 |
| Mar ’25 | CHF 85.80 | CHF 87.00 +1.4% | 10.2% | CHF 102.00 | CHF 80.00 | n/a | 4 |
| Feb ’25 | CHF 85.50 | CHF 87.00 +1.8% | 10.2% | CHF 102.00 | CHF 80.00 | n/a | 4 |
| Jan ’25 | CHF 99.90 | CHF 93.50 -6.4% | 15.5% | CHF 118.00 | CHF 81.00 | n/a | 4 |
| Dec ’24 | CHF 92.80 | CHF 93.50 +0.8% | 15.5% | CHF 118.00 | CHF 81.00 | n/a | 4 |
| Nov ’24 | CHF 86.40 | CHF 92.25 +6.8% | 16.2% | CHF 118.00 | CHF 81.00 | n/a | 4 |
| Oct ’24 | CHF 77.90 | CHF 95.80 +23.0% | 15.8% | CHF 118.00 | CHF 81.00 | n/a | 5 |
| Sep ’24 | CHF 78.50 | CHF 98.33 +25.3% | 15.2% | CHF 118.00 | CHF 81.00 | n/a | 6 |
| Aug ’24 | CHF 97.60 | CHF 115.33 +18.2% | 14.6% | CHF 139.00 | CHF 90.00 | n/a | 6 |
| Jul ’24 | CHF 98.10 | CHF 118.83 +21.1% | 19.0% | CHF 160.00 | CHF 90.00 | CHF 92.70 | 6 |
| Jun ’24 | CHF 116.40 | CHF 123.00 +5.7% | 18.8% | CHF 160.00 | CHF 90.00 | CHF 95.70 | 6 |
| May ’24 | CHF 107.60 | CHF 123.00 +14.3% | 18.8% | CHF 160.00 | CHF 90.00 | CHF 85.10 | 6 |
| Apr ’24 | CHF 127.80 | CHF 123.00 -3.8% | 18.8% | CHF 160.00 | CHF 90.00 | CHF 86.80 | 6 |
| Mar ’24 | CHF 107.80 | CHF 121.17 +12.4% | 20.0% | CHF 160.00 | CHF 90.00 | CHF 85.80 | 6 |
| Feb ’24 | CHF 108.60 | CHF 122.83 +13.1% | 19.1% | CHF 160.00 | CHF 90.00 | CHF 85.50 | 6 |
| Jan ’24 | CHF 110.20 | CHF 127.00 +15.2% | 19.3% | CHF 160.00 | CHF 80.00 | CHF 99.90 | 6 |
| Dec ’23 | CHF 121.60 | CHF 128.67 +5.8% | 19.6% | CHF 160.00 | CHF 80.00 | CHF 92.80 | 6 |
| Nov ’23 | CHF 99.70 | CHF 128.67 +29.1% | 19.6% | CHF 160.00 | CHF 80.00 | CHF 86.40 | 6 |
| Oct ’23 | CHF 120.60 | CHF 128.67 +6.7% | 19.6% | CHF 160.00 | CHF 80.00 | CHF 77.90 | 6 |
| Sep ’23 | CHF 135.80 | CHF 113.17 -16.7% | 20.0% | CHF 145.00 | CHF 80.00 | CHF 78.50 | 6 |
| Aug ’23 | CHF 111.00 | CHF 89.13 -19.7% | 15.3% | CHF 110.00 | CHF 70.00 | CHF 97.60 | 6 |
| Jul ’23 | CHF 94.30 | CHF 84.67 -10.2% | 13.5% | CHF 100.00 | CHF 70.00 | CHF 98.10 | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.